Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Behan P. O., Haniffah B. A. Gangliosides and neurological diseases. BMJ. 1992 Nov 28;305(6865):1309–1310. doi: 10.1136/bmj.305.6865.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cuello A. C. Glycosphingolipids that can regulate nerve growth and repair. Adv Pharmacol. 1990;21:1–50. doi: 10.1016/s1054-3589(08)60338-5. [DOI] [PubMed] [Google Scholar]
- Devi R. S., Namasivayam A. Modulation of specific immunity by ventral hippocampal formation in albino rats. J Neuroimmunol. 1991 Jul;33(1):1–6. doi: 10.1016/0165-5728(91)90028-6. [DOI] [PubMed] [Google Scholar]
- Geisler F. H., Dorsey F. C., Coleman W. P. Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med. 1991 Jun 27;324(26):1829–1838. doi: 10.1056/NEJM199106273242601. [DOI] [PubMed] [Google Scholar]
- Marcus D. M. A review of the immunogenic and immuno-modulatory properties of glycosphingolipids. Mol Immunol. 1984 Nov;21(11):1083–1091. doi: 10.1016/0161-5890(84)90118-4. [DOI] [PubMed] [Google Scholar]
- Nobile-Orazio E., Legname G., Daverio R., Carpo M., Giuliani A., Sonnino S., Scarlato G. Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins. Ann Neurol. 1990 Aug;28(2):190–194. doi: 10.1002/ana.410280215. [DOI] [PubMed] [Google Scholar]
- Svennerholm L., Fredman P. Antibody detection in Guillain-Barré syndrome. Ann Neurol. 1990;27 (Suppl):S36–S40. doi: 10.1002/ana.410270710. [DOI] [PubMed] [Google Scholar]